Home › Trial NCT03642535
Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention
- Trial IDNCT03642535
- StatusUnknown
- PhasePhase 4
- Study typeInterventional
- SponsorShanghai Dermatology Hospital
- Enrollment300
- Start date2018-08-30
- ConditionsActinic Keratoses
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.